JPWO2020141459A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020141459A5 JPWO2020141459A5 JP2021538386A JP2021538386A JPWO2020141459A5 JP WO2020141459 A5 JPWO2020141459 A5 JP WO2020141459A5 JP 2021538386 A JP2021538386 A JP 2021538386A JP 2021538386 A JP2021538386 A JP 2021538386A JP WO2020141459 A5 JPWO2020141459 A5 JP WO2020141459A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- integer
- conjugate
- alkyl
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024178721A JP2025020143A (ja) | 2019-01-03 | 2024-10-11 | 切断可能なリンカーを含む化合物及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788013P | 2019-01-03 | 2019-01-03 | |
| US62/788,013 | 2019-01-03 | ||
| PCT/IB2020/000018 WO2020141459A1 (en) | 2019-01-03 | 2020-01-03 | Compounds comprising cleavable linker and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024178721A Division JP2025020143A (ja) | 2019-01-03 | 2024-10-11 | 切断可能なリンカーを含む化合物及びその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022515884A JP2022515884A (ja) | 2022-02-22 |
| JPWO2020141459A5 true JPWO2020141459A5 (https=) | 2023-01-19 |
| JP2022515884A5 JP2022515884A5 (https=) | 2023-01-19 |
| JP7657152B2 JP7657152B2 (ja) | 2025-04-04 |
Family
ID=71407393
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538386A Active JP7657152B2 (ja) | 2019-01-03 | 2020-01-03 | 切断可能なリンカーを含む化合物及びその使用 |
| JP2024178721A Withdrawn JP2025020143A (ja) | 2019-01-03 | 2024-10-11 | 切断可能なリンカーを含む化合物及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024178721A Withdrawn JP2025020143A (ja) | 2019-01-03 | 2024-10-11 | 切断可能なリンカーを含む化合物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220118104A1 (https=) |
| EP (1) | EP3906064A4 (https=) |
| JP (2) | JP7657152B2 (https=) |
| KR (1) | KR20210099660A (https=) |
| CN (2) | CN113453726A (https=) |
| AU (1) | AU2020205160A1 (https=) |
| BR (1) | BR112021012365A2 (https=) |
| CA (1) | CA3124758A1 (https=) |
| EA (1) | EA202191854A1 (https=) |
| MX (1) | MX2021008095A (https=) |
| WO (1) | WO2020141459A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019008441A1 (en) | 2017-07-04 | 2019-01-10 | Intocell, Inc. | COMPOUNDS COMPRISING A CLIABABLE BIT AND USES THEREOF |
| WO2020141460A2 (en) | 2019-01-03 | 2020-07-09 | Intocell, Inc. | Compounds comprising cleavable linker and uses thereof |
| IL322315A (en) | 2019-05-14 | 2025-09-01 | Provention Bio Inc | Methods and preparations for preventing type 1 diabetes |
| AU2021287998B2 (en) | 2020-06-11 | 2026-03-12 | Benaroya Research Institute At Virginia Mason | Methods and compositions for preventing type 1 diabetes |
| US12565529B2 (en) | 2021-05-24 | 2026-03-03 | Provention Bio, Inc. | Methods for treating type 1 diabetes |
| WO2025237246A1 (en) * | 2024-05-11 | 2025-11-20 | Westlake Laboratory Of Life Sciences And Biomedicine | Novel covalent protein and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105899539B (zh) * | 2014-01-10 | 2021-11-09 | 博笛生物科技有限公司 | 用于免疫疗法的化合物和组合物 |
| KR101628872B1 (ko) * | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| CN107922375B (zh) * | 2015-07-30 | 2020-05-22 | 正大天晴药业集团股份有限公司 | 靶向idh2突变的抗肿瘤化合物及其使用方法 |
| KR101766822B1 (ko) * | 2015-09-10 | 2017-08-24 | 서울대학교산학협력단 | 디페닐설페이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 c형 간염 바이러스 관련 질환의 예방 또는 치료용 약학적 조성물 |
| WO2018124758A2 (ko) * | 2016-12-28 | 2018-07-05 | 주식회사 인투셀 | 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물 |
| WO2019008441A1 (en) * | 2017-07-04 | 2019-01-10 | Intocell, Inc. | COMPOUNDS COMPRISING A CLIABABLE BIT AND USES THEREOF |
| MX2020012718A (es) * | 2018-05-29 | 2021-02-16 | Intocell Inc | Derivados de benzodiazepinas novedosos y usos de los mismos. |
| KR20210068591A (ko) * | 2018-10-31 | 2021-06-09 | 주식회사 인투셀 | 융합된 헤테로시클릭 벤조디아제핀 유도체 및 그의 용도 |
-
2020
- 2020-01-03 EP EP20736028.0A patent/EP3906064A4/en active Pending
- 2020-01-03 JP JP2021538386A patent/JP7657152B2/ja active Active
- 2020-01-03 MX MX2021008095A patent/MX2021008095A/es unknown
- 2020-01-03 EA EA202191854A patent/EA202191854A1/ru unknown
- 2020-01-03 WO PCT/IB2020/000018 patent/WO2020141459A1/en not_active Ceased
- 2020-01-03 AU AU2020205160A patent/AU2020205160A1/en active Pending
- 2020-01-03 BR BR112021012365-2A patent/BR112021012365A2/pt unknown
- 2020-01-03 CN CN202080013390.XA patent/CN113453726A/zh active Pending
- 2020-01-03 CA CA3124758A patent/CA3124758A1/en active Pending
- 2020-01-03 CN CN202111625947.8A patent/CN114306634A/zh active Pending
- 2020-01-03 KR KR1020217024245A patent/KR20210099660A/ko not_active Ceased
- 2020-01-03 US US17/419,030 patent/US20220118104A1/en active Pending
-
2024
- 2024-10-11 JP JP2024178721A patent/JP2025020143A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020527599A5 (https=) | ||
| JP7393810B2 (ja) | 部位特異的抗体コンジュゲーション及びその具体例としての抗体－薬物コンジュゲート | |
| TWI715611B (zh) | 抗體藥物偶聯物的共價鍵連接子及其製備方法與應用 | |
| JP7682789B2 (ja) | Ｂ７－Ｈ３のＩｇＶドメインに対するモノクローナル抗体及びその使用 | |
| US12521444B2 (en) | Anti-HER2 antibody-drug conjugates and uses thereof | |
| CN112543752A (zh) | 连接子、含连接子的抗体偶联药物及连接子的用途 | |
| KR20200041914A (ko) | 면역자극제 톨-유사 수용체 7 (tlr7) 효능제로서의 6-아미노-7,9-디히드로-8h-퓨린-8-온 유도체 | |
| US20160229920A1 (en) | Targeting her2 and her3 with bispecific antibodies in cancerous cells | |
| KR20200041913A (ko) | 면역자극제로서 톨-유사 수용체 7 (tlr7) 효능제로서의 6-아미노-7,9-디히드로-8h-퓨린-8-온 유도체 | |
| CN112204039A (zh) | 荧光性化合物及使用了该荧光性化合物的荧光标记生物物质 | |
| CN102614521A (zh) | 利用白蛋白-结合蛋白作为靶标的治疗方法 | |
| JPWO2020141460A5 (https=) | ||
| EP4603109A1 (en) | Antibody-drug conjugate, preparation method therefor, and use thereof | |
| CN113490678B (zh) | 荧光gtp类似物和用途 | |
| JPWO2020141459A5 (https=) | ||
| Figini et al. | Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor | |
| KR102014383B1 (ko) | G 단백질 연결 수용체의 활성 조절 인간 항체 | |
| US20240309099A1 (en) | Bispecific tetravalent antibody targeting egfr and her3 | |
| Calce et al. | HER2-mediated anticancer drug delivery: strategies to prepare targeting ligands highly specific for the receptor | |
| JPWO2019229536A5 (https=) | ||
| RU2020104697A (ru) | Соединения, содержащие расщепляемый линкер, и способы их применения | |
| CN117659133B (zh) | 间皮素靶向结合蛋白、其编码核酸以及用途 | |
| WO2025036480A1 (zh) | 化合物以及含有该化合物的抗体偶联药物 | |
| JP2025507736A (ja) | 投薬レジメン | |
| JP2023511189A (ja) | Ｓｅｍｇ２抗体およびその使用 |